Loading insider details...
Beta
Latest Form 4 (Aug 4, 2026): Sale of 1,900 RARE shares, $47.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 1,900 | $47.3K |
| Jun 15, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 1,899 | $46.8K |
| May 29, 2026 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 120,000 | n/a |
| Apr 20, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 28,895 | n/a |
| Mar 10, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 6,018 | $128.8K |
| Mar 3, 2026 | Ultragenyx Pharmaceutical Inc. (RARE) | Grant/Award | 11,137 | n/a |
| Feb 20, 2026 | Evolus, Inc. (EOLS) | Grant/Award | 45,559 | n/a |
| Sep 12, 2025 | Ultragenyx Pharmaceutical Inc. (RARE) | Sale | 2,450 | $76.4K |
| May 30, 2025 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 107,400 | n/a |
| Mar 14, 2025 | Evolus, Inc. (EOLS) | Sale | 12,888 | $167.5K |